<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://pharmacopedia.wiki/index.php?action=history&amp;feed=atom&amp;title=Sodium_Chloride</id>
	<title>Sodium Chloride - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://pharmacopedia.wiki/index.php?action=history&amp;feed=atom&amp;title=Sodium_Chloride"/>
	<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Sodium_Chloride&amp;action=history"/>
	<updated>2026-05-28T06:43:31Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.46.0-beta</generator>
	<entry>
		<id>https://pharmacopedia.wiki/index.php?title=Sodium_Chloride&amp;diff=6509&amp;oldid=prev</id>
		<title>MDElliottMD: home-claude house-rule fix (terminology / spelling)</title>
		<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Sodium_Chloride&amp;diff=6509&amp;oldid=prev"/>
		<updated>2026-05-23T04:44:07Z</updated>

		<summary type="html">&lt;p&gt;home-claude house-rule fix (terminology / spelling)&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw-interface=&quot;&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 04:44, 23 May 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l6&quot;&gt;Line 6:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 6:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| structure         =&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| structure         =&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| classes           = [[:Category:Crystalloid_IV_fluids|Crystalloid IV fluid]], [[:Category:Electrolyte_replacements|Electrolyte replacement]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| classes           = [[:Category:Crystalloid_IV_fluids|Crystalloid IV fluid]], [[:Category:Electrolyte_replacements|Electrolyte replacement]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| uses              = &amp;lt;vote slug=&quot;volume-resuscitation-use&quot;&amp;gt;Volume resuscitation&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&quot;maintenance-iv-fluid-use&quot;&amp;gt;Maintenance IV fluid&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&quot;hyponatremia-use&quot;&amp;gt;Hyponatremia (3% hypertonic for symptomatic)&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&quot;cystic-fibrosis-airway-clearance-use&quot;&amp;gt;Nebulized 3-7% for cystic fibrosis airway clearance&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&quot;iv-medication-diluent-use&quot;&amp;gt;IV &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;medication &lt;/del&gt;diluent&amp;lt;/vote&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| uses              = &amp;lt;vote slug=&quot;volume-resuscitation-use&quot;&amp;gt;Volume resuscitation&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&quot;maintenance-iv-fluid-use&quot;&amp;gt;Maintenance IV fluid&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&quot;hyponatremia-use&quot;&amp;gt;Hyponatremia (3% hypertonic for symptomatic)&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&quot;cystic-fibrosis-airway-clearance-use&quot;&amp;gt;Nebulized 3-7% for cystic fibrosis airway clearance&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&quot;iv-medication-diluent-use&quot;&amp;gt;IV &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;medicine &lt;/ins&gt;diluent&amp;lt;/vote&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| starting_dose     = Volume and concentration titrated to clinical status; symptomatic hyponatremia: 3% NaCl 100-150 mL bolus, reassess&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| starting_dose     = Volume and concentration titrated to clinical status; symptomatic hyponatremia: 3% NaCl 100-150 mL bolus, reassess&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| preparations      = 0.225%, 0.45%, 0.9%, 3%, 5% IV solutions; 0.9% nasal spray; 3% and 7% nebulizer solutions; oral tablets (1 g)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| preparations      = 0.225%, 0.45%, 0.9%, 3%, 5% IV solutions; 0.9% nasal spray; 3% and 7% nebulizer solutions; oral tablets (1 g)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>MDElliottMD</name></author>
	</entry>
	<entry>
		<id>https://pharmacopedia.wiki/index.php?title=Sodium_Chloride&amp;diff=6502&amp;oldid=prev</id>
		<title>MDElliottMD: home-claude punt-list stub-split, Top 300 #227</title>
		<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Sodium_Chloride&amp;diff=6502&amp;oldid=prev"/>
		<updated>2026-05-23T04:41:15Z</updated>

		<summary type="html">&lt;p&gt;home-claude punt-list stub-split, Top 300 #227&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Sodium chloride is the principal extracellular electrolyte salt, used clinically as an intravenous crystalloid (most commonly 0.9% &amp;quot;normal saline&amp;quot;), oral or parenteral electrolyte replacement, hypertonic solution for symptomatic hyponatremia, nebulized irrigant in cystic fibrosis and bronchiectasis, ophthalmic decongestant, and pharmaceutical diluent&amp;lt;ref name=&amp;quot;nacl-label&amp;quot;&amp;gt;FDA Prescribing Information, 0.9% Sodium Chloride Injection, Baxter, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018324s039lbl.pdf&amp;lt;/ref&amp;gt;. Normal saline (154 mEq/L Na+ and 154 mEq/L Cl-) is the most widely administered medicinal product in the world.&lt;br /&gt;
&lt;br /&gt;
{{MedTemplate&lt;br /&gt;
| generic           = Sodium chloride&lt;br /&gt;
| brand             = Normal saline, NaCl injection, many; nebulized: HyperSal, PulmoSal&lt;br /&gt;
| structure         =&lt;br /&gt;
| classes           = [[:Category:Crystalloid_IV_fluids|Crystalloid IV fluid]], [[:Category:Electrolyte_replacements|Electrolyte replacement]]&lt;br /&gt;
| uses              = &amp;lt;vote slug=&amp;quot;volume-resuscitation-use&amp;quot;&amp;gt;Volume resuscitation&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;maintenance-iv-fluid-use&amp;quot;&amp;gt;Maintenance IV fluid&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;hyponatremia-use&amp;quot;&amp;gt;Hyponatremia (3% hypertonic for symptomatic)&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;cystic-fibrosis-airway-clearance-use&amp;quot;&amp;gt;Nebulized 3-7% for cystic fibrosis airway clearance&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;iv-medication-diluent-use&amp;quot;&amp;gt;IV medication diluent&amp;lt;/vote&amp;gt;&lt;br /&gt;
| starting_dose     = Volume and concentration titrated to clinical status; symptomatic hyponatremia: 3% NaCl 100-150 mL bolus, reassess&lt;br /&gt;
| preparations      = 0.225%, 0.45%, 0.9%, 3%, 5% IV solutions; 0.9% nasal spray; 3% and 7% nebulizer solutions; oral tablets (1 g)&lt;br /&gt;
| fda_max           = No fixed maximum; titrated; sodium correction rate in chronic hyponatremia must not exceed 8-10 mEq/L per 24 hours to avoid osmotic demyelination&lt;br /&gt;
| pill_id           =&lt;br /&gt;
| routes            = IV, oral, nebulized, intranasal, ophthalmic&lt;br /&gt;
| onset             = Immediate (IV)&lt;br /&gt;
| duration          = Roughly 20-25% of an IV bolus remains intravascular at 1 hour&lt;br /&gt;
| halflife          = Not applicable (electrolyte)&lt;br /&gt;
| bioavailability   = 100% (IV); essentially complete (oral)&lt;br /&gt;
| pregnancy         = Standard fluid and electrolyte management&lt;br /&gt;
| legal             = [[USLegal:Prescription only|Rx-only]] for parenteral formulations; OTC for oral, nasal, and many nebulizer products&lt;br /&gt;
| mechanism         = &amp;lt;vote slug=&amp;quot;nacl-mech-claim&amp;quot;&amp;gt;Sodium chloride solutions expand the extracellular volume in proportion to their tonicity; high-volume 0.9% saline reliably produces hyperchloremic metabolic acidosis, which is why balanced crystalloids like Lactated Ringer&amp;#039;s are often preferred for large-volume resuscitation.&amp;lt;/vote&amp;gt; Hypertonic 3% is the standard urgent treatment of severely symptomatic hyponatremia&amp;lt;ref name=&amp;quot;nacl-label&amp;quot; /&amp;gt;.&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>MDElliottMD</name></author>
	</entry>
</feed>